{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:30:14Z","timestamp":1769085014329,"version":"3.49.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1940,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Department of Scientific Research and Structural Funds of Medical College, Jagiellonian University","doi-asserted-by":"publisher","award":["SAP N41\/DBS\/000130"],"award-info":[{"award-number":["SAP N41\/DBS\/000130"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["SAP N41\/DBS\/000130"],"award-info":[{"award-number":["SAP N41\/DBS\/000130"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aims of this paper were to investigate the analytical performance of the nine prognostic scales commonly used in heart failure (HF), in patients with dilated cardiomyopathy (DCM), and to develop a unique prognostic model tailored to DCM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The hospital and outpatient records of 406 DCM patients were retrospectively analysed. The information on patient status was gathered after 48.2 \u00b1 32.0 months. Tests were carried out to ascertain the prognostic accuracy in DCM using some of the most frequently applied HF prognostic scales (Barcelona Bio-Heart Failure, Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity, Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure, Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure, Meta-Analysis Global Group in Chronic Heart Failure, MUerte Subita en Insuficiencia Cardiaca, Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure, Seattle Heart Failure Model) and one dedicated to DCM, that of Miura et al. At follow-up, 70 DCM patients (17.2%) died. Most analysed scores substantially overestimated the mortality risk, especially in survivors. The prognostic accuracy of the scales were suboptimal, varying between 60% and 80%, with the best performance from Barcelona Bio-Heart Failure and Seattle Heart Failure Model for 1\u20135 year mortality [areas under the receiver operating curve 0.792\u20130.890 (95% confidence interval 0.725\u20130.918) and 0.764\u20130.808 (95% confidence interval 0.682\u20130.934), respectively].Based on our accumulated data, a self-developed DCM prognostic model was constructed. The model consists of age, gender, body mass index, symptoms duration, New York Heart Association class, diabetes mellitus, prior stroke, abnormal liver function, dyslipidaemia, left bundle branch block, left ventricle end-diastolic diameter, ejection fraction, N terminal pro brain natriuretic peptide, haemoglobin, estimated glomerular filtration rate, and pharmacological and resynchronisation therapy. This newly created prognostic model outperformed the analysed HF scales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An analysis of various HF prognostic models found them to be suboptimal for DCM patients. A self-developed DCM prognostic model showed improved performance over the nine other models studied. However, further validation of the prognostic model in different DCM populations is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12809","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T14:46:16Z","timestamp":1598539576000},"page":"2455-2467","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mortality Risk in Dilated Cardiomyopathy: The Accuracy of Heart Failure Prognostic Models and Dilated Cardiomyopathy-Tailored Prognostic Model"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7921-5447","authenticated-orcid":false,"given":"Ewa","family":"Dziewi\u0119cka*","sequence":"first","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Jagiellonian University Collegium Medicum, John Paul II Hospital , Pr\u0105dnicka Street 80, Krak\u00f3w, 31-202 ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matylda","family":"Gliniak","sequence":"additional","affiliation":[{"name":"Jagiellonian University Collegium Medicum, Students' Scientific Group at the Department of Cardiac and Vascular Diseases, John Paul II Hospital , Krakow ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Winiarczyk","sequence":"additional","affiliation":[{"name":"Jagiellonian University Collegium Medicum, Students' Scientific Group at the Department of Cardiac and Vascular Diseases, John Paul II Hospital , Krakow ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Karapetyan","sequence":"additional","affiliation":[{"name":"Jagiellonian University Collegium Medicum, Students' Scientific Group at the Department of Cardiac and Vascular Diseases, John Paul II Hospital , Krakow ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Wi\u015bniowska-\u015amia\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Jagiellonian University Collegium Medicum, John Paul II Hospital , Pr\u0105dnicka Street 80, Krak\u00f3w, 31-202 ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Karabinowska","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Jagiellonian University Collegium Medicum, John Paul II Hospital , Pr\u0105dnicka Street 80, Krak\u00f3w, 31-202 ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Dziewi\u0119cki","sequence":"additional","affiliation":[{"name":"College of Economics and Computer Science , Krak\u00f3w ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Podolec","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Jagiellonian University Collegium Medicum, John Paul II Hospital , Pr\u0105dnicka Street 80, Krak\u00f3w, 31-202 ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Rubi\u015b","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Jagiellonian University Collegium Medicum, John Paul II Hospital , Pr\u0105dnicka Street 80, Krak\u00f3w, 31-202 ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"2026012114050524800_ehf212809-bib-0001","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ejhf.949","article-title":"Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization","volume":"20","author":"Lup\u00f3n","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"2026012114050524800_ehf212809-bib-0003","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012114050524800_ehf212809-bib-0004","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/eht247","article-title":"The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial","volume":"34","author":"Collier","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012114050524800_ehf212809-bib-0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCHEARTFAILURE.112.967828","article-title":"Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial. Proposal for a nomogram","volume":"6","author":"Barlera","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure. Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0007","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"2026012114050524800_ehf212809-bib-0008","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp032","article-title":"The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure","volume":"30","author":"Vazquez","year":"2009","journal-title":"Eur Heart J"},{"key":"2026012114050524800_ehf212809-bib-0009","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ejhf.1202","article-title":"Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study","volume":"20","author":"Iorio","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0011","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jacep.2019.04.001","article-title":"Performance of prognostic heart failure models in patients with nonischemic cardiomyopathy undergoing ventricular tachycardia ablation","volume":"5","author":"Muser","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012114050524800_ehf212809-bib-0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006233","article-title":"Mortality and sudden cardiac death risk stratification using the noninvasive combination of wide QRS duration and late gadolinium enhancement in idiopathic dilated cardiomyopathy","volume":"11","author":"Marume","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012114050524800_ehf212809-bib-0013","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.transproceed.2017.11.060","article-title":"Prognostic value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure","volume":"50","author":"Sobrino-M\u00e1rquez","year":"2018","journal-title":"Transplant Proc"},{"key":"2026012114050524800_ehf212809-bib-0014","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/eurjhf\/hft019","article-title":"Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy","volume":"15","author":"Gulati","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0015","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.113.002518","article-title":"The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy","volume":"128","author":"Gulati","year":"2013","journal-title":"Circulation"},{"key":"2026012114050524800_ehf212809-bib-0016","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ijcard.2012.11.061","article-title":"Initial white blood cell count is an independent risk factor for survival in patients with dilated cardiomyopathy","volume":"168","author":"Riad","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0017","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2459\/JCM.0b013e328356a2fd","article-title":"Renal function has an effect on cardiovascular mortality in patients with dilated cardiomyopathy","volume":"13","author":"Erta\u015f","year":"2012","journal-title":"J Cardiovasc Med"},{"key":"2026012114050524800_ehf212809-bib-0018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1542-474X.2011.00442.x","article-title":"Fragmented QRS is sssociated with all-cause mortality and ventricular arrhythmias in patient with idiopathic dilated cardiomyopathy","volume":"16","author":"Sha","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026012114050524800_ehf212809-bib-0019","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3121\/cmr.2010.908","article-title":"Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste","volume":"8","author":"Aleksova","year":"2010","journal-title":"Clin Med Res"},{"key":"2026012114050524800_ehf212809-bib-0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2143\/AC.64.3.2038020","article-title":"Outcome of patients with dilated cardiomyopathy in a contemporary Swiss population","volume":"64","author":"Vischer","year":"2009","journal-title":"Acta Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.acvd.2015.10.006","article-title":"Right ventricular dysfunction in patients with idiopathic dilated cardiomyopathy: prognostic value and predictive factors","volume":"109","author":"Venner","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"2026012114050524800_ehf212809-bib-0022","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1253\/circj.72.343","article-title":"Prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan. Results From a Nationwide Study","volume":"72","author":"Miura","year":"2008","journal-title":"Circ J"},{"key":"2026012114050524800_ehf212809-bib-0023","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejrad.2019.06.004","article-title":"Using machine learning to predict one-year cardiovascular events in patients with severe dilated cardiomyopathy","volume":"117","author":"Chen","year":"2019","journal-title":"Eur J Radiol"},{"key":"2026012114050524800_ehf212809-bib-0024","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","article-title":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment","volume":"57","author":"Merlo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0025","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.1216","article-title":"Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy","volume":"20","author":"Halliday","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0026","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijcard.2016.06.167","article-title":"Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy","volume":"220","author":"Karatolios","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0027","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejhf.16","article-title":"Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years","volume":"16","author":"Merlo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012114050524800_ehf212809-bib-0028","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"2026012114050524800_ehf212809-bib-0029","first-page":"19","article-title":"The diagnostic work-up of genetic and inflammatory dilated cardiomyopathy","volume":"13","author":"Rubi\u015b","year":"2015","journal-title":"E-J Cardiol Pract"},{"key":"2026012114050524800_ehf212809-bib-0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012114050524800_ehf212809-bib-0031","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Hear Fail"},{"key":"2026012114050524800_ehf212809-bib-0032","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijcard.2016.07.232","article-title":"Prognostic value of cardiopulmonary exercise testing in idiopathic dilated cardiomyopathy","volume":"223","author":"Sinagra","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0033","first-page":"37","article-title":"Sex differences in the long-term prognosis of dilated cardiomyopathy","volume":"36","author":"Cannat\u00e0","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026012114050524800_ehf212809-bib-0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085466","article-title":"Development of a novel heart failure risk tool: the Barcelona Bio-Heart Failure risk calculator (BCN bio-HF calculator)","volume":"9","author":"Lup\u00f3n","year":"2014","journal-title":"PLoS ONE"},{"key":"2026012114050524800_ehf212809-bib-0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","article-title":"Prediction of mode of death in heart failure: The Seattle Heart Failure Model","volume":"116","author":"Mozaffarian","year":"2007","journal-title":"Circulation"},{"key":"2026012114050524800_ehf212809-bib-0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2019.5850","article-title":"Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure","volume":"5","author":"Simpson","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12809","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12809","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/2455\/65807125\/eschf_7_5_2455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/2455\/65807125\/eschf_7_5_2455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:05:37Z","timestamp":1769022337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/5\/2455\/8372026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,8,27]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12809","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"2020-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}